Author

Oscar Krijgsman

The Netherlands Cancer InstituteORCID 0000-0003-0825-3291Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Oscar Krijgsman1 paper

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell signaling & trafficking· 1 Assay:DNA methylation· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

Carolina FurtadoiD· 1 shared Daniel Andrade MoreiraiD· 1 shared Daniel S. PeeperiD· 1 shared Danielle Gonçalves de Carvalho· 1 shared João P. B. ViolaiD· 1 shared Juliana C.N. KenskiiD· 1 shared Mariana BoroniiD· 1 shared Matheus Andrade Rajão· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

9 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Carolina FurtadoORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologyPharmacological ResearchPeer-reviewedMay 23, 2025

Resistance to BRAF inhibitors drives melanoma sensitivity to Chk1 inhibition

Danielle Gonçalves de Carvalho, Juliana C.N. Kenski, Daniel Andrade Moreira…·Patrícia A. Possik

This study shows BRAF inhibitor-resistant melanoma cells are more sensitive to Chk1 inhibition due to increased replication stress, suggesting Chk1i could overcome MAPK inhibitor resistance.

4 citations

humanproteomics

𝕏 PostBluesky